uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Sevsury
Application withdrawn
Human
Details
EMA number
EMEA/H/C/005728
ATC code
L01EX01
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of progressive neuroendocrine tumours
MeSH:
Neuroendocrine Tumors
Group:
Antineoplastic agents
Active substances
surufatinib
Marketing Authorisation Holder
Hutchmed Europe B.V.
MAH
Sevsury | uMedical